Qingdao Vland Biotech Co Ltd Capital Reinvestment Ratio
Qingdao Vland Biotech Co Ltd capital reinvestment ratio. Qingdao Vland Biotech Co Ltd (603739) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.29 Million) in capital expenditures (CN¥7.42 Million). Check Qingdao Vland Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Qingdao Vland Biotech Co Ltd (2014–2024)
Capital reinvestment ratio of Qingdao Vland Biotech Co Ltd from 2014 to 2024. This chart tracks Qingdao Vland Biotech Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore Qingdao Vland Biotech Co Ltd (603739) equity growth momentum to track the company's year-over-year net asset growth rate.
Qingdao Vland Biotech Co Ltd Capital Reinvestment Ratio by Year (2014–2024)
Qingdao Vland Biotech Co Ltd capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see 603739 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | CN¥195.41 Million | CN¥104.72 Million | ▼ -61.8% |
| 2023 | 1.40x | CN¥153.59 Million | CN¥215.64 Million | ▼ -60.9% |
| 2022 | 3.59x | CN¥95.31 Million | CN¥342.02 Million | ▼ -34.9% |
| 2021 | 5.51x | CN¥89.51 Million | CN¥493.58 Million | ▲ +350.3% |
| 2020 | 1.22x | CN¥173.00 Million | CN¥211.83 Million | ▼ -33.4% |
| 2019 | 1.84x | CN¥65.33 Million | CN¥120.17 Million | ▲ +120.4% |
| 2018 | 0.83x | CN¥85.75 Million | CN¥71.56 Million | ▲ +75.3% |
| 2017 | 0.48x | CN¥121.90 Million | CN¥58.05 Million | ▲ +177.1% |
| 2016 | 0.17x | CN¥154.49 Million | CN¥26.55 Million | ▼ -76.9% |
| 2015 | 0.74x | CN¥74.27 Million | CN¥55.32 Million | ▼ -14.4% |
| 2014 | 0.87x | CN¥58.55 Million | CN¥50.93 Million | — |